首页> 美国卫生研究院文献>Neurologia medico-chirurgica >Guidelines for Mechanical Thrombectomy in Japan the Fourth Edition March 2020: A Guideline from the Japan Stroke Society the Japan Neurosurgical Society and the Japanese Society for Neuroendovascular Therapy
【2h】

Guidelines for Mechanical Thrombectomy in Japan the Fourth Edition March 2020: A Guideline from the Japan Stroke Society the Japan Neurosurgical Society and the Japanese Society for Neuroendovascular Therapy

机译:日本机械血栓切除术指南第四版3月2020年3月:日本中风会日本神经外科学会和日本神经血管治疗学会的指导方针

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute cerebral artery occlusion is associated with very poor outcomes.1) Early recanalization of occluded arteries, however, may improve the outcome, and recanalization therapy has been attempted with a variety of approaches. The most well-known approach is intravenous therapy with the recombinant tissue-plasminogen activator (IV rt-PA), alteplase. The efficacy of IV rt-PA has been established through many randomized controlled trials (RCTs).2,3) IV rt-PA is classified as a Class I therapy in the Guidelines for the Early Management of Patients with Acute Ischemic Stroke of the American Heart Association/American Stroke Association (AHA/ASA)4) and a Grade A recommendation in the Japanese Guidelines for the Management of Stroke.5) Even as cerebrovascular medical technology has progressed, IV rt-PA remains the priority therapy for patients with acute ischemic stroke. Currently, IV rt-PA is indicated for acute ischemic stroke within 4.5 hours of onset with no contraindications.6,7)
机译:急性脑动脉闭塞与非常差的结果有关.1)然而,闭塞动脉的早期再生可能改善结果,并尝试了各种方法的重组治疗。最着名的方法是用重组组织 - 纤溶酶原激活剂(IV RT-PA),Alteplase静脉治疗。已经通过许多随机对照试验(RCT)来确定IV RT-PA的疗效.2,3)IV RT-PA被归类为I级治疗,在美国急性缺血性卒中患者的早期管理的准则中心脏协会/美国中风协会(AHA / ASA)4)和日本中风指南的一级建议,即使脑血管医疗技术已经进展,IV RT-PA仍然是急性患者的优先疗法缺血性中风。目前,IV RT-PA在4.5小时内显示出急性缺血性卒中,没有禁忌症.6,7)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号